| (210) | Number of the EPO application | 21165852 |
| (220) | Filing date of the EPO application | 2015.12.23 |
| (80) | EPO patent specification publication (B) | EPB nr. 07/2023, 2023.02.15 |
| (110) | EPO patent number | 3882250 |
| (11) | Number of the document | MD 3882250 T2 |
| (21) | Number of the application | e 2022 0501 |
| (71) | Name(s) of applicant(s), code of the country | ArQule, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | LAPIERRE Jean-Marc, US;
EATHIRAJ Sudharshan, US;
NAMDEV Nivedita, US;
SCHWARTZ Brian, US;
OTA Yusuke, JP;
MOMOSE Takayuki, JP;
TSUNEMI Tomoyuki, JP;
INAGAKI Hiroaki, JP;
NAKAYAMA Kiyoshi, JP; |
| (73) | Name(s) of owner(s), code of the country | ArQule, Inc., US; |
| (54) | Title of the invention | Tetrahydropyranyl amino-pyrrolopyrimidinone for use in treating btk-mediated disorders |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 487/04 (1974.07.01); C07D 405/12 (1974.07.01); A61K 31/519 (2000.01.01); A61P 35/00 (2000.01.01); A61P 29/00 (2000.01.01); A61P 31/12 (2000.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2022.05.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.06.30 |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |